1,25-dihydroxyergocalciferol has been researched along with Cirrhosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brennan, EP; Cullen, C; Godson, C; Nolan, KA; Ryan, A; Scholz, CC; Taylor, CT | 1 |
1 other study(ies) available for 1,25-dihydroxyergocalciferol and Cirrhosis
Article | Year |
---|---|
Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia.
Topics: Actins; Basic Helix-Loop-Helix Transcription Factors; Cadherins; Calcium-Binding Proteins; Cell Hypoxia; Cell Line, Transformed; Epithelial Cells; Ergocalciferols; Fibrosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Kidney; Membrane Proteins; Nephritis, Interstitial; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Stability; RNA Interference; Serrate-Jagged Proteins; Smad2 Protein; Thrombospondin 1; Transforming Growth Factor beta1 | 2015 |